September 24, 2019 – Accel-Rx, Canada’s health sciences accelerator, has been recognized as the ‘Best Health Science Accelerator in Canada,’ and ‘Seed Investment Experts of the Year’ in the 2019 Global Healthcare & Pharmaceutical (GHP) Awards. The winners of the awards honour those who provide the highest quality of care and medical products available, and pay homage to those whose innovative work within the life sciences industry contributes towards furthering the advancement of health in an ever-expanding and demanding sector.
As seed investment specialists, Accel-Rx stewards early-stage companies selected from across the country to a level where they can successfully raise a Series A or equivalent financing. Through a unique growth platform that provides access to capital, industry connections, mentorship and customized guidance, the Accel-Rx formula is designed to stimulate Canada’s health sciences sector and ensure our innovations become competitive on a global scale.
Katherine Benton, GHP Awards Co-ordinator, explains: “These awards highlight, beyond a shadow of a doubt, that our winners outshine the competition and are committed to giving their service users the support they need. With the healthcare and pharmaceutical markets among the most important in the entire corporate landscape, I am proud to be able to showcase the winners of this prestigious awards programme for 2019.”
Read all about the reasons behind Accel-Rx’s win here.